{"transactions":[{"id":743393,"issuer":{"id":4394,"kind":"organization","name":"Rapport Therapeutics, Inc.","symbol":"RAPP"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T21:28:25.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":15200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest upon the earlier of (i) June 10, 2027 and (ii) the date of the next Annual Meeting of Stockholders of the Issuer, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":15200,"derivative":{"exercise_price":35.21,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":15200},"source":{"system":"sec-edgar","filing":"0001193125-26-266099","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2012593/000119312526266099/ownership.xml","form_type":"4"}},{"id":776958,"issuer":{"id":1156,"kind":"organization","name":"Nurix Therapeutics, Inc.","symbol":"NRIX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-05-15T21:56:53.000Z","date":"2026-05-15","kind":"grant","planned":false,"acquired":true,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 100% of the award on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) May 15, 2027, in each case, subject to the Reporting Person's provision of service to the Issuer on such vesting date."}],"balance_after":31250,"derivative":{"exercise_price":15.86,"expiration_date":"2036-05-14","underlying":"Common Stock","underlying_shares":31250},"source":{"system":"sec-edgar","filing":"0001446372-26-000002","document":"wk-form4_1778882211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446372/000144637226000002/wk-form4_1778882211.xml","form_type":"4"}},{"id":1106586,"issuer":{"id":4394,"kind":"organization","name":"Rapport Therapeutics, Inc.","symbol":"RAPP"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-18T20:15:05.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":10925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest upon the earlier of (i) June 17, 2026 and (ii) the date of the next Annual Meeting of Stockholders of the Issuer, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":10925,"derivative":{"exercise_price":10.95,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":10925},"source":{"system":"sec-edgar","filing":"0000950170-25-087896","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2012593/000095017025087896/ownership.xml","form_type":"4"}},{"id":1142534,"issuer":{"id":1156,"kind":"organization","name":"Nurix Therapeutics, Inc.","symbol":"NRIX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-05-19T21:33:49.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 100% of the award on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) May 19, 2026, in each case, subject to the Reporting Person's provision of service to the Issuer on such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":9.51,"expiration_date":"2035-05-18","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001549595-25-000083","document":"wk-form4_1747690420.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446372/000154959525000083/wk-form4_1747690420.xml","form_type":"4"}},{"id":1373104,"issuer":{"id":4394,"kind":"organization","name":"Rapport Therapeutics, Inc.","symbol":"RAPP"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-07T23:59:13.000Z","date":"2024-11-07","kind":"grant","planned":false,"acquired":true,"shares":29756,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares underlying this option shall vest and become exercisable on November 7, 2025, with the remaining shares vesting in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":29756,"derivative":{"exercise_price":26.9,"expiration_date":"2034-11-07","underlying":"Common Stock","underlying_shares":29756},"source":{"system":"sec-edgar","filing":"0000950170-24-123607","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2012593/000095017024123607/ownership.xml","form_type":"4"}},{"id":1508891,"issuer":{"id":1156,"kind":"organization","name":"Nurix Therapeutics, Inc.","symbol":"NRIX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2024-05-20T23:26:23.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 100% of the award on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) May 20, 2025, in each case, subject to the Reporting Person's provision of service to the Issuer on such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":16.19,"expiration_date":"2034-05-19","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001549595-24-000069","document":"wk-form4_1716247571.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446372/000154959524000069/wk-form4_1716247571.xml","form_type":"4"}},{"id":1904325,"issuer":{"id":1156,"kind":"organization","name":"Nurix Therapeutics, Inc.","symbol":"NRIX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2023-05-05T00:00:13.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 100% of the award on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) May 4, 2024, in each case, subject to the Reporting Person's provision of service to the Issuer on such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":9.44,"expiration_date":"2033-05-03","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-23-027514","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446372/000120919123027514/doc4.xml","form_type":"4"}},{"id":2279225,"issuer":{"id":1156,"kind":"organization","name":"Nurix Therapeutics, Inc.","symbol":"NRIX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2022-05-06T21:44:38.000Z","date":"2022-05-05","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 100% of the award on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) May 5, 2023, in each case, subject to the Reporting Person's provision of service to the Issuer on such vesting date."}],"balance_after":17500,"derivative":{"exercise_price":10.39,"expiration_date":"2032-05-04","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001209191-22-027669","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446372/000120919122027669/doc4.xml","form_type":"4"}},{"id":2551901,"issuer":{"id":1156,"kind":"organization","name":"Nurix Therapeutics, Inc.","symbol":"NRIX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2021-10-04T21:15:50.000Z","date":"2021-10-01","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 1/36 of the total shares monthly beginning November 1, 2021 until the option is fully vested on October 1, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":35000,"derivative":{"exercise_price":31.24,"expiration_date":"2031-09-30","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-21-059061","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446372/000120919121059061/doc4.xml","form_type":"4"}},{"id":379098,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-03-02T21:07:21.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":231,"price":213.12,"value":49230.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $213.12 (range $212.96 to $213.27)."}],"balance_after":9884,"source":{"system":"sec-edgar","filing":"0001209191-21-015849","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121015849/doc4.xml","form_type":"4"}},{"id":379097,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-03-02T21:07:21.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":915,"price":212.51,"value":194446.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $212.51 (range $211.96 to $212.85)."}],"balance_after":10115,"source":{"system":"sec-edgar","filing":"0001209191-21-015849","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121015849/doc4.xml","form_type":"4"}},{"id":379096,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-03-02T21:07:21.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":610,"price":211.45,"value":128984.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $211.45 (range $210.96 to $211.95)."}],"balance_after":11030,"source":{"system":"sec-edgar","filing":"0001209191-21-015849","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121015849/doc4.xml","form_type":"4"}},{"id":379095,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-03-02T21:07:21.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":1026,"price":210.13,"value":215593.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $210.13 (range $209.93 to $210.77)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":11640,"source":{"system":"sec-edgar","filing":"0001209191-21-015849","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121015849/doc4.xml","form_type":"4"}},{"id":379094,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-03-02T21:07:21.000Z","date":"2021-02-26","kind":"tax_withholding","acquired":false,"shares":2218,"price":212.42,"value":471147.56,"ownership":{"direct":true},"balance_after":12666,"source":{"system":"sec-edgar","filing":"0001209191-21-015849","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121015849/doc4.xml","form_type":"4"}},{"id":379372,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-02-26T21:23:27.000Z","date":"2021-02-25","kind":"sale","acquired":false,"shares":126,"price":216.25,"value":27247.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $216.25 (range $215.79 to $216.76)."}],"balance_after":14884,"source":{"system":"sec-edgar","filing":"0001209191-21-014749","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121014749/doc4.xml","form_type":"4"}},{"id":379371,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-02-26T21:23:27.000Z","date":"2021-02-25","kind":"sale","acquired":false,"shares":258,"price":214.32,"value":55294.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $214.32 (range $213.90 to $214.69)."}],"balance_after":15010,"source":{"system":"sec-edgar","filing":"0001209191-21-014749","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121014749/doc4.xml","form_type":"4"}},{"id":379370,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-02-26T21:23:27.000Z","date":"2021-02-25","kind":"sale","acquired":false,"shares":452,"price":213.12,"value":96330.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $213.12 (range $212.82 to $213.79)."}],"balance_after":15268,"source":{"system":"sec-edgar","filing":"0001209191-21-014749","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121014749/doc4.xml","form_type":"4"}},{"id":379369,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-02-26T21:23:27.000Z","date":"2021-02-25","kind":"sale","acquired":false,"shares":244,"price":211.8,"value":51679.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $211.80 (range $211.57 to $212.07)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":15720,"source":{"system":"sec-edgar","filing":"0001209191-21-014749","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121014749/doc4.xml","form_type":"4"}},{"id":379368,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-02-26T21:23:27.000Z","date":"2021-02-24","kind":"tax_withholding","acquired":false,"shares":864,"price":217.57,"value":187980.48,"ownership":{"direct":true},"balance_after":15964,"source":{"system":"sec-edgar","filing":"0001209191-21-014749","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121014749/doc4.xml","form_type":"4"}},{"id":379867,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-02-19T21:21:53.000Z","date":"2021-02-18","kind":"sale","acquired":false,"shares":1368,"price":212.62,"value":290864.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $212.62 (range $212.15 to $213.14)."}],"balance_after":16828,"source":{"system":"sec-edgar","filing":"0001209191-21-012355","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121012355/doc4.xml","form_type":"4"}},{"id":379866,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-02-19T21:21:53.000Z","date":"2021-02-18","kind":"sale","acquired":false,"shares":2343,"price":211.82,"value":496294.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $211.82 (range $211.15 to $212.14)."}],"balance_after":18196,"source":{"system":"sec-edgar","filing":"0001209191-21-012355","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121012355/doc4.xml","form_type":"4"}},{"id":379865,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-02-19T21:21:53.000Z","date":"2021-02-18","kind":"sale","acquired":false,"shares":584,"price":210.05,"value":122669.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $210.05 (range $209.59 to $210.37)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":20539,"source":{"system":"sec-edgar","filing":"0001209191-21-012355","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121012355/doc4.xml","form_type":"4"}},{"id":379864,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-02-19T21:21:53.000Z","date":"2021-02-17","kind":"tax_withholding","acquired":false,"shares":2740,"price":211.75,"value":580195.0,"ownership":{"direct":true},"balance_after":21123,"source":{"system":"sec-edgar","filing":"0001209191-21-012355","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121012355/doc4.xml","form_type":"4"}},{"id":380315,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-02-16T21:24:51.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":210,"price":211.32,"value":44377.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $211.32 (range $211.10 to $211.50)."}],"balance_after":23863,"source":{"system":"sec-edgar","filing":"0001209191-21-010739","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121010739/doc4.xml","form_type":"4"}},{"id":380314,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-02-16T21:24:51.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":1288,"price":210.45,"value":271059.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $210.45 (range $209.91 to $210.77)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":24073,"source":{"system":"sec-edgar","filing":"0001209191-21-010739","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121010739/doc4.xml","form_type":"4"}},{"id":380485,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-02-12T21:16:19.000Z","date":"2021-02-10","kind":"tax_withholding","acquired":false,"shares":651,"price":214.16,"value":139418.16,"ownership":{"direct":true},"balance_after":25361,"source":{"system":"sec-edgar","filing":"0001209191-21-010125","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121010125/doc4.xml","form_type":"4"}},{"id":380782,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-02-05T21:57:27.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":3634,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Restricted stock unit award that vests in installments beginning on 02/17/2022."}],"balance_after":26012,"source":{"system":"sec-edgar","filing":"0001209191-21-008149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121008149/doc4.xml","form_type":"4"}},{"id":380781,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-02-05T21:57:27.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":3226,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/05/2020 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/03/2021 and the shares will vest in installments beginning on 02/10/2021."}],"balance_after":22378,"source":{"system":"sec-edgar","filing":"0001209191-21-008149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121008149/doc4.xml","form_type":"4"}},{"id":380780,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2021-02-05T21:57:27.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":4220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/06/2018 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/03/2021 and the shares will vest on 02/17/2021."}],"balance_after":19152,"source":{"system":"sec-edgar","filing":"0001209191-21-008149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121008149/doc4.xml","form_type":"4"}},{"id":387442,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-10T20:24:34.000Z","date":"2020-08-06","kind":"exercise","acquired":false,"shares":612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option vests in 16 quarterly installments from 02/06/2018."}],"balance_after":3669,"derivative":{"exercise_price":155.57,"expiration_date":"2028-02-05","underlying":"Common Stock","underlying_shares":612},"source":{"system":"sec-edgar","filing":"0001209191-20-045942","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120045942/doc4.xml","form_type":"4"}},{"id":387441,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-10T20:24:34.000Z","date":"2020-08-06","kind":"exercise","acquired":false,"shares":466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vests in 16 quarterly installments from 02/06/2019."}],"balance_after":4656,"derivative":{"exercise_price":187.53,"expiration_date":"2029-02-05","underlying":"Common Stock","underlying_shares":466},"source":{"system":"sec-edgar","filing":"0001209191-20-045942","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120045942/doc4.xml","form_type":"4"}},{"id":387440,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-08-10T20:24:34.000Z","date":"2020-08-06","kind":"sale","acquired":false,"shares":74,"price":272.87,"value":20192.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $272.87 (range $272.78 to $273.08)."}],"balance_after":14932,"source":{"system":"sec-edgar","filing":"0001209191-20-045942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120045942/doc4.xml","form_type":"4"}},{"id":387439,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-08-10T20:24:34.000Z","date":"2020-08-06","kind":"sale","acquired":false,"shares":373,"price":272.15,"value":101511.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $272.15 (range $271.76 to $272.75)."}],"balance_after":15006,"source":{"system":"sec-edgar","filing":"0001209191-20-045942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120045942/doc4.xml","form_type":"4"}},{"id":387438,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-08-10T20:24:34.000Z","date":"2020-08-06","kind":"sale","acquired":false,"shares":211,"price":270.92,"value":57164.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $270.92 (range $270.73 to $271.34)."}],"balance_after":15379,"source":{"system":"sec-edgar","filing":"0001209191-20-045942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120045942/doc4.xml","form_type":"4"}},{"id":387437,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-08-10T20:24:34.000Z","date":"2020-08-06","kind":"sale","acquired":false,"shares":420,"price":270.12,"value":113450.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $270.12 (range $269.62 to $270.59)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":15590,"source":{"system":"sec-edgar","filing":"0001209191-20-045942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120045942/doc4.xml","form_type":"4"}},{"id":387436,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-08-10T20:24:34.000Z","date":"2020-08-06","kind":"exercise","acquired":true,"shares":612,"price":155.57,"value":95208.84,"ownership":{"direct":true},"balance_after":16010,"source":{"system":"sec-edgar","filing":"0001209191-20-045942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120045942/doc4.xml","form_type":"4"}},{"id":387435,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-08-10T20:24:34.000Z","date":"2020-08-06","kind":"exercise","acquired":true,"shares":466,"price":187.53,"value":87388.98,"ownership":{"direct":true},"balance_after":15398,"source":{"system":"sec-edgar","filing":"0001209191-20-045942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120045942/doc4.xml","form_type":"4"}},{"id":387550,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-05T20:24:22.000Z","date":"2020-08-03","kind":"exercise","acquired":false,"shares":809,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests in 16 quarterly installments from 02/03/2017."}],"balance_after":1618,"derivative":{"exercise_price":86.52,"expiration_date":"2027-02-02","underlying":"Common Stock","underlying_shares":809},"source":{"system":"sec-edgar","filing":"0001209191-20-045105","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120045105/doc4.xml","form_type":"4"}},{"id":387549,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-08-05T20:24:22.000Z","date":"2020-08-03","kind":"sale","acquired":false,"shares":19,"price":279.61,"value":5312.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."}],"balance_after":14932,"source":{"system":"sec-edgar","filing":"0001209191-20-045105","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120045105/doc4.xml","form_type":"4"}},{"id":387548,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-08-05T20:24:22.000Z","date":"2020-08-03","kind":"sale","acquired":false,"shares":429,"price":278.92,"value":119656.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $278.92 (range $278.47 to $279.38)."}],"balance_after":14951,"source":{"system":"sec-edgar","filing":"0001209191-20-045105","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120045105/doc4.xml","form_type":"4"}},{"id":387547,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-08-05T20:24:22.000Z","date":"2020-08-03","kind":"sale","acquired":false,"shares":310,"price":277.73,"value":86096.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $277.73 (range $277.25 to $278.22)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":15380,"source":{"system":"sec-edgar","filing":"0001209191-20-045105","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120045105/doc4.xml","form_type":"4"}},{"id":387546,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-08-05T20:24:22.000Z","date":"2020-08-03","kind":"sale","acquired":false,"shares":51,"price":276,"value":14076.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."}],"balance_after":15690,"source":{"system":"sec-edgar","filing":"0001209191-20-045105","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120045105/doc4.xml","form_type":"4"}},{"id":387545,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-08-05T20:24:22.000Z","date":"2020-08-03","kind":"exercise","acquired":true,"shares":809,"price":86.52,"value":69994.68,"ownership":{"direct":true},"balance_after":15741,"source":{"system":"sec-edgar","filing":"0001209191-20-045105","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120045105/doc4.xml","form_type":"4"}},{"id":388283,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-07-15T20:51:49.000Z","date":"2020-07-13","kind":"exercise","acquired":false,"shares":860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":90.29,"expiration_date":"2026-07-11","underlying":"Common Stock","underlying_shares":860},"source":{"system":"sec-edgar","filing":"0001209191-20-042492","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120042492/doc4.xml","form_type":"4"}},{"id":388282,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-07-15T20:51:49.000Z","date":"2020-07-13","kind":"sale","acquired":false,"shares":100,"price":295.78,"value":29578.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Open market sales reported on this line occurred at a weighted average price of $295.78 (range $295.75 to $295.80)."}],"balance_after":14932,"source":{"system":"sec-edgar","filing":"0001209191-20-042492","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120042492/doc4.xml","form_type":"4"}},{"id":388281,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-07-15T20:51:49.000Z","date":"2020-07-13","kind":"sale","acquired":false,"shares":250,"price":294.99,"value":73747.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Open market sales reported on this line occurred at a weighted average price of $294.99 (range $294.68 to $295.42)."}],"balance_after":15032,"source":{"system":"sec-edgar","filing":"0001209191-20-042492","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120042492/doc4.xml","form_type":"4"}},{"id":388280,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-07-15T20:51:49.000Z","date":"2020-07-13","kind":"sale","acquired":false,"shares":200,"price":294.18,"value":58836.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $294.18 (range $293.67 to $294.39)."}],"balance_after":15282,"source":{"system":"sec-edgar","filing":"0001209191-20-042492","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120042492/doc4.xml","form_type":"4"}},{"id":388279,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-07-15T20:51:49.000Z","date":"2020-07-13","kind":"sale","acquired":false,"shares":50,"price":291.97,"value":14598.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."}],"balance_after":15482,"source":{"system":"sec-edgar","filing":"0001209191-20-042492","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120042492/doc4.xml","form_type":"4"}},{"id":388278,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-07-15T20:51:49.000Z","date":"2020-07-13","kind":"sale","acquired":false,"shares":100,"price":287.86,"value":28786.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $287.86 (range $287.85 to $287.86)."}],"balance_after":15532,"source":{"system":"sec-edgar","filing":"0001209191-20-042492","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120042492/doc4.xml","form_type":"4"}},{"id":388277,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-07-15T20:51:49.000Z","date":"2020-07-13","kind":"sale","acquired":false,"shares":60,"price":285.71,"value":17142.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $285.71 (range $285.59 to $285.83)."}],"balance_after":15632,"source":{"system":"sec-edgar","filing":"0001209191-20-042492","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120042492/doc4.xml","form_type":"4"}},{"id":388276,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-07-15T20:51:49.000Z","date":"2020-07-13","kind":"sale","acquired":false,"shares":100,"price":284.56,"value":28456.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $284.56 (range $284.37 to $284.74)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":15692,"source":{"system":"sec-edgar","filing":"0001209191-20-042492","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120042492/doc4.xml","form_type":"4"}},{"id":388275,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-07-15T20:51:49.000Z","date":"2020-07-13","kind":"exercise","acquired":true,"shares":860,"price":90.29,"value":77649.4,"ownership":{"direct":true},"balance_after":15792,"source":{"system":"sec-edgar","filing":"0001209191-20-042492","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120042492/doc4.xml","form_type":"4"}},{"id":390323,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-05-19T20:31:31.000Z","date":"2020-05-15","kind":"sale","acquired":false,"shares":47,"price":288.04,"value":13537.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Open market sales reported on this line occurred at a weighted average price of $288.04 (range $287.77 to $288.47)."}],"balance_after":14932,"source":{"system":"sec-edgar","filing":"0001209191-20-030487","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120030487/doc4.xml","form_type":"4"}},{"id":390322,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-05-19T20:31:31.000Z","date":"2020-05-15","kind":"sale","acquired":false,"shares":14,"price":287,"value":4018.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $287.00 (range $286.76 to $287.75)."}],"balance_after":14979,"source":{"system":"sec-edgar","filing":"0001209191-20-030487","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120030487/doc4.xml","form_type":"4"}},{"id":390321,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-05-19T20:31:31.000Z","date":"2020-05-15","kind":"sale","acquired":false,"shares":20,"price":285.51,"value":5710.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $285.51 (range $285.37 to $285.64)."}],"balance_after":14993,"source":{"system":"sec-edgar","filing":"0001209191-20-030487","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120030487/doc4.xml","form_type":"4"}},{"id":390320,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-05-19T20:31:31.000Z","date":"2020-05-15","kind":"sale","acquired":false,"shares":10,"price":282.85,"value":2828.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."}],"balance_after":15013,"source":{"system":"sec-edgar","filing":"0001209191-20-030487","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120030487/doc4.xml","form_type":"4"}},{"id":390319,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-05-19T20:31:31.000Z","date":"2020-05-15","kind":"sale","acquired":false,"shares":20,"price":281.81,"value":5636.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $281.81 (range $281.62 to $282.00)."}],"balance_after":15023,"source":{"system":"sec-edgar","filing":"0001209191-20-030487","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120030487/doc4.xml","form_type":"4"}},{"id":390318,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-05-19T20:31:31.000Z","date":"2020-05-15","kind":"sale","acquired":false,"shares":30,"price":279.89,"value":8396.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $279.89 (range $279.42 to $280.19)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":15043,"source":{"system":"sec-edgar","filing":"0001209191-20-030487","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120030487/doc4.xml","form_type":"4"}},{"id":390317,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-05-19T20:31:31.000Z","date":"2020-05-15","kind":"sale","acquired":false,"shares":10,"price":275.71,"value":2757.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."}],"balance_after":15073,"source":{"system":"sec-edgar","filing":"0001209191-20-030487","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120030487/doc4.xml","form_type":"4"}},{"id":390896,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-08T20:26:33.000Z","date":"2020-05-06","kind":"exercise","acquired":false,"shares":611,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The option vests in 16 quarterly installments from 02/06/2018."}],"balance_after":4281,"derivative":{"exercise_price":155.57,"expiration_date":"2028-02-05","underlying":"Common Stock","underlying_shares":611},"source":{"system":"sec-edgar","filing":"0001209191-20-027904","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027904/doc4.xml","form_type":"4"}},{"id":390895,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-08T20:26:33.000Z","date":"2020-05-06","kind":"exercise","acquired":false,"shares":465,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option vests in 16 quarterly installments from 02/06/2019."}],"balance_after":5122,"derivative":{"exercise_price":187.53,"expiration_date":"2029-02-05","underlying":"Common Stock","underlying_shares":465},"source":{"system":"sec-edgar","filing":"0001209191-20-027904","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027904/doc4.xml","form_type":"4"}},{"id":390894,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-05-08T20:26:33.000Z","date":"2020-05-06","kind":"sale","acquired":false,"shares":70,"price":275.17,"value":19261.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Open market sales reported on this line occurred5 at a weighted average price of $275.17 (range $275.07 to $275.30)."}],"balance_after":14932,"source":{"system":"sec-edgar","filing":"0001209191-20-027904","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027904/doc4.xml","form_type":"4"}},{"id":390893,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-05-08T20:26:33.000Z","date":"2020-05-06","kind":"sale","acquired":false,"shares":210,"price":274.41,"value":57626.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Open market sales reported on this line occurred5 at a weighted average price of $274.41 (range $274.05 to $274.65)."}],"balance_after":15002,"source":{"system":"sec-edgar","filing":"0001209191-20-027904","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027904/doc4.xml","form_type":"4"}},{"id":390892,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-05-08T20:26:33.000Z","date":"2020-05-06","kind":"sale","acquired":false,"shares":240,"price":273.53,"value":65647.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $273.53 (range $273.03 to $273.90)."}],"balance_after":15212,"source":{"system":"sec-edgar","filing":"0001209191-20-027904","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027904/doc4.xml","form_type":"4"}},{"id":390891,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-05-08T20:26:33.000Z","date":"2020-05-06","kind":"sale","acquired":false,"shares":328,"price":272.4,"value":89347.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $272.40 (range $272.03 to $272.98)."}],"balance_after":15452,"source":{"system":"sec-edgar","filing":"0001209191-20-027904","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027904/doc4.xml","form_type":"4"}},{"id":390890,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-05-08T20:26:33.000Z","date":"2020-05-06","kind":"sale","acquired":false,"shares":149,"price":270.51,"value":40305.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $270.51 (range $270.00 to $270.75)."}],"balance_after":15780,"source":{"system":"sec-edgar","filing":"0001209191-20-027904","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027904/doc4.xml","form_type":"4"}},{"id":390889,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-05-08T20:26:33.000Z","date":"2020-05-06","kind":"sale","acquired":false,"shares":79,"price":269.41,"value":21283.39,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $269.41 (range $268.97 to $269.87)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":15929,"source":{"system":"sec-edgar","filing":"0001209191-20-027904","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027904/doc4.xml","form_type":"4"}},{"id":390888,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-05-08T20:26:33.000Z","date":"2020-05-06","kind":"exercise","acquired":true,"shares":611,"price":155.57,"value":95053.27,"ownership":{"direct":true},"balance_after":16008,"source":{"system":"sec-edgar","filing":"0001209191-20-027904","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027904/doc4.xml","form_type":"4"}},{"id":390887,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-05-08T20:26:33.000Z","date":"2020-05-06","kind":"exercise","acquired":true,"shares":465,"price":187.53,"value":87201.45,"ownership":{"direct":true},"balance_after":15397,"source":{"system":"sec-edgar","filing":"0001209191-20-027904","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027904/doc4.xml","form_type":"4"}},{"id":391110,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-06T20:27:35.000Z","date":"2020-05-04","kind":"exercise","acquired":false,"shares":809,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option vests in 16 quarterly installments from 02/03/2017."}],"balance_after":2427,"derivative":{"exercise_price":86.52,"expiration_date":"2027-02-02","underlying":"Common Stock","underlying_shares":809},"source":{"system":"sec-edgar","filing":"0001209191-20-027476","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027476/doc4.xml","form_type":"4"}},{"id":391109,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-05-06T20:27:35.000Z","date":"2020-05-04","kind":"sale","acquired":false,"shares":59,"price":264.75,"value":15620.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Open market sales reported on this line occurred at a weighted average price of $264.75 (range $264.59 to $264.89)."}],"balance_after":14932,"source":{"system":"sec-edgar","filing":"0001209191-20-027476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027476/doc4.xml","form_type":"4"}},{"id":391108,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-05-06T20:27:35.000Z","date":"2020-05-04","kind":"sale","acquired":false,"shares":100,"price":262.83,"value":26283.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $262.83 (range $262.74 to $262.92)."}],"balance_after":14991,"source":{"system":"sec-edgar","filing":"0001209191-20-027476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027476/doc4.xml","form_type":"4"}},{"id":391107,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-05-06T20:27:35.000Z","date":"2020-05-04","kind":"sale","acquired":false,"shares":200,"price":261.55,"value":52310.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $261.55 (range $261.13 to $262.11)."}],"balance_after":15091,"source":{"system":"sec-edgar","filing":"0001209191-20-027476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027476/doc4.xml","form_type":"4"}},{"id":391106,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-05-06T20:27:35.000Z","date":"2020-05-04","kind":"sale","acquired":false,"shares":250,"price":259.97,"value":64992.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $259.97 (range $259.72 to $260.33)."}],"balance_after":15291,"source":{"system":"sec-edgar","filing":"0001209191-20-027476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027476/doc4.xml","form_type":"4"}},{"id":391105,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-05-06T20:27:35.000Z","date":"2020-05-04","kind":"sale","acquired":false,"shares":200,"price":259.21,"value":51842.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $259.21 (range $258.62 to $259.60)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":15541,"source":{"system":"sec-edgar","filing":"0001209191-20-027476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027476/doc4.xml","form_type":"4"}},{"id":391104,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-05-06T20:27:35.000Z","date":"2020-05-04","kind":"exercise","acquired":true,"shares":809,"price":86.52,"value":69994.68,"ownership":{"direct":true},"balance_after":15741,"source":{"system":"sec-edgar","filing":"0001209191-20-027476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027476/doc4.xml","form_type":"4"}},{"id":391947,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-15T20:15:24.000Z","date":"2020-04-13","kind":"exercise","acquired":false,"shares":859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option vests in 16 quarterly installments from 07/12/2016."}],"balance_after":860,"derivative":{"exercise_price":90.29,"expiration_date":"2026-07-11","underlying":"Common Stock","underlying_shares":859},"source":{"system":"sec-edgar","filing":"0001209191-20-024476","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120024476/doc4.xml","form_type":"4"}},{"id":391946,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-04-15T20:15:24.000Z","date":"2020-04-13","kind":"sale","acquired":false,"shares":166,"price":252.26,"value":41875.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Open market sales reported on this line occurred at a weighted average price of $252.26 (range $251.99 to $252.85)."}],"balance_after":14932,"source":{"system":"sec-edgar","filing":"0001209191-20-024476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120024476/doc4.xml","form_type":"4"}},{"id":391945,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-04-15T20:15:24.000Z","date":"2020-04-13","kind":"sale","acquired":false,"shares":193,"price":250.29,"value":48305.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $250.29 (range $249.95 to $250.54)."}],"balance_after":15098,"source":{"system":"sec-edgar","filing":"0001209191-20-024476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120024476/doc4.xml","form_type":"4"}},{"id":391944,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-04-15T20:15:24.000Z","date":"2020-04-13","kind":"sale","acquired":false,"shares":150,"price":248.96,"value":37344.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $248.96 (range $248.75 to $249.30)."}],"balance_after":15291,"source":{"system":"sec-edgar","filing":"0001209191-20-024476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120024476/doc4.xml","form_type":"4"}},{"id":391943,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-04-15T20:15:24.000Z","date":"2020-04-13","kind":"sale","acquired":false,"shares":150,"price":247.18,"value":37077.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $247.18 (range $246.88 to $247.44)."}],"balance_after":15441,"source":{"system":"sec-edgar","filing":"0001209191-20-024476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120024476/doc4.xml","form_type":"4"}},{"id":391942,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-04-15T20:15:24.000Z","date":"2020-04-13","kind":"sale","acquired":false,"shares":150,"price":245.62,"value":36843.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $245.62 (range $245.31 to $246.00)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":15591,"source":{"system":"sec-edgar","filing":"0001209191-20-024476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120024476/doc4.xml","form_type":"4"}},{"id":391941,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-04-15T20:15:24.000Z","date":"2020-04-13","kind":"sale","acquired":false,"shares":50,"price":244.09,"value":12204.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."}],"balance_after":15741,"source":{"system":"sec-edgar","filing":"0001209191-20-024476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120024476/doc4.xml","form_type":"4"}},{"id":391940,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-04-15T20:15:24.000Z","date":"2020-04-13","kind":"exercise","acquired":true,"shares":859,"price":90.29,"value":77559.11,"ownership":{"direct":true},"balance_after":15791,"source":{"system":"sec-edgar","filing":"0001209191-20-024476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120024476/doc4.xml","form_type":"4"}},{"id":392072,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-08T20:17:48.000Z","date":"2020-04-06","kind":"exercise","acquired":false,"shares":4891,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in 16 quarterly installments from 02/06/2018."}],"balance_after":4892,"derivative":{"exercise_price":155.57,"expiration_date":"2028-02-05","underlying":"Common Stock","underlying_shares":4891},"source":{"system":"sec-edgar","filing":"0001209191-20-023914","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120023914/doc4.xml","form_type":"4"}},{"id":392071,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-04-08T20:17:48.000Z","date":"2020-04-06","kind":"sale","acquired":false,"shares":4891,"price":255.57,"value":1249992.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."}],"balance_after":14932,"source":{"system":"sec-edgar","filing":"0001209191-20-023914","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120023914/doc4.xml","form_type":"4"}},{"id":392070,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-04-08T20:17:48.000Z","date":"2020-04-06","kind":"exercise","acquired":true,"shares":4891,"price":155.57,"value":760892.87,"ownership":{"direct":true},"balance_after":19823,"source":{"system":"sec-edgar","filing":"0001209191-20-023914","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120023914/doc4.xml","form_type":"4"}},{"id":394343,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-02-26T21:37:36.000Z","date":"2020-02-25","kind":"sale","acquired":false,"shares":150,"price":238.4,"value":35760.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Open market sales reported on this line occurred at a weighted average price of $238.40 (range $238.19 to $238.54)."}],"balance_after":14932,"source":{"system":"sec-edgar","filing":"0001209191-20-013037","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120013037/doc4.xml","form_type":"4"}},{"id":394342,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-02-26T21:37:36.000Z","date":"2020-02-25","kind":"sale","acquired":false,"shares":90,"price":236.85,"value":21316.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Open market sales reported on this line occurred at a weighted average price of $236.85 (range $236.65 to $237.24)."}],"balance_after":15082,"source":{"system":"sec-edgar","filing":"0001209191-20-013037","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120013037/doc4.xml","form_type":"4"}},{"id":394341,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-02-26T21:37:36.000Z","date":"2020-02-25","kind":"sale","acquired":false,"shares":150,"price":235.49,"value":35323.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Open market sales reported on this line occurred at a weighted average price of $235.49 (range $235.15 to $235.87)."}],"balance_after":15172,"source":{"system":"sec-edgar","filing":"0001209191-20-013037","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120013037/doc4.xml","form_type":"4"}},{"id":394340,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-02-26T21:37:36.000Z","date":"2020-02-25","kind":"sale","acquired":false,"shares":150,"price":234.5,"value":35175.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $234.50 (range $234.14 to $235.10)."}],"balance_after":15322,"source":{"system":"sec-edgar","filing":"0001209191-20-013037","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120013037/doc4.xml","form_type":"4"}},{"id":394339,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-02-26T21:37:36.000Z","date":"2020-02-25","kind":"sale","acquired":false,"shares":120,"price":232.4,"value":27888.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $232.40 (range $232.37 to $232.44)."}],"balance_after":15472,"source":{"system":"sec-edgar","filing":"0001209191-20-013037","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120013037/doc4.xml","form_type":"4"}},{"id":394338,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-02-26T21:37:36.000Z","date":"2020-02-25","kind":"sale","acquired":false,"shares":137,"price":231.17,"value":31670.29,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $231.17 (range $230.73 to $231.47)."}],"balance_after":15592,"source":{"system":"sec-edgar","filing":"0001209191-20-013037","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120013037/doc4.xml","form_type":"4"}},{"id":394337,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-02-26T21:37:36.000Z","date":"2020-02-25","kind":"sale","acquired":false,"shares":283,"price":229.66,"value":64993.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $229.66 (range $229.20 to $230.14)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":15729,"source":{"system":"sec-edgar","filing":"0001209191-20-013037","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120013037/doc4.xml","form_type":"4"}},{"id":394336,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-02-26T21:37:36.000Z","date":"2020-02-24","kind":"tax_withholding","acquired":false,"shares":864,"price":239.23,"value":206694.72,"ownership":{"direct":true},"balance_after":16012,"source":{"system":"sec-edgar","filing":"0001209191-20-013037","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120013037/doc4.xml","form_type":"4"}},{"id":394878,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-02-19T21:38:51.000Z","date":"2020-02-18","kind":"sale","acquired":false,"shares":202,"price":245.74,"value":49639.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Open market sales reported on this line occurred at a weighted average price of $245.74 (range $245.55 to $245.86.)"}],"balance_after":16876,"source":{"system":"sec-edgar","filing":"0001209191-20-010554","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120010554/doc4.xml","form_type":"4"}},{"id":394877,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-02-19T21:38:51.000Z","date":"2020-02-18","kind":"sale","acquired":false,"shares":280,"price":245,"value":68600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $245.00 (range $244.52 to $245.43.)"}],"balance_after":17078,"source":{"system":"sec-edgar","filing":"0001209191-20-010554","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120010554/doc4.xml","form_type":"4"}},{"id":394876,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-02-19T21:38:51.000Z","date":"2020-02-18","kind":"sale","acquired":false,"shares":202,"price":243.85,"value":49257.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $243.85 (range $243.52 to $244.29)."}],"balance_after":17358,"source":{"system":"sec-edgar","filing":"0001209191-20-010554","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120010554/doc4.xml","form_type":"4"}},{"id":394875,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-02-19T21:38:51.000Z","date":"2020-02-18","kind":"sale","acquired":false,"shares":640,"price":242.8,"value":155392.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $242.80 (range $242.45 to $243.32)."}],"balance_after":17560,"source":{"system":"sec-edgar","filing":"0001209191-20-010554","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120010554/doc4.xml","form_type":"4"}},{"id":394874,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":15694,"kind":"person","name":"Silva Paul M","position":1,"cik":"0001446372","reported_name":"Silva Paul M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Controller"}}],"security":"Common Stock","published_at":"2020-02-19T21:38:51.000Z","date":"2020-02-18","kind":"sale","acquired":false,"shares":240,"price":241.95,"value":58068.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $241.95 (range $241.43 to $242.40)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":18200,"source":{"system":"sec-edgar","filing":"0001209191-20-010554","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120010554/doc4.xml","form_type":"4"}}],"next_cursor":"2020-02-19T21:38:51.000000Z,394874"}